BTF Northwest Women’s Cancer Conference

Portland, OR US
September 21, 2024

The “BTF Northwest Women’s Cancer Conference” is a CME-accredited activity featuring experts in breast cancer and gynecologic malignancies. The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with breast cancer and gynecologic malignancies. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in the field. Expert faculty will aim to place the role of different therapeutic agents in the clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care.

This women's cancer conference will augment healthcare providers’ foundation of knowledge and clinical competence in the management of women’s cancers.

Target Audience

  • Medical Oncologists
  • Surgical Oncologists
  • Radiation Oncologists
  • Gynecological Oncologists
  • Oncology Fellows
  • Oncology Nurses
  • Nurse Practitioners
  • Physician Assistants
  • Oncology Pharmacists

ORGANIZING COMMITTEE: 

Course Director:

Binay Shah, MD, MHA - Binaytara Foundation

Conference Chair:

Fengting Yan, MD - Swedish Health Services

Learning Objectives

Upon successful completion of this educational activity, participants will be able to:

  • Evaluate the available clinical trials for women's cancers, including eligibility criteria and outcomes.
  • Summarize the current guidelines for the management of women’s cancers, focusing on best practices and recommended treatments.
  • Analyze the study design and primary endpoints of recently reported and ongoing clinical trials assessing novel strategies for women’s cancer management.
  • Identify frequent molecular abnormalities in women’s cancers and determine the appropriate timing for testing to detect these abnormalities.
  • Integrate emerging evidence in precision oncology into current treatment paradigms for women’s cancers, enhancing personalized management of disease. 

HOTEL INFORMATION

A limited number of rooms have been booked at the Hyatt Regency Portland at the Oregon Convention Center at a discounted nightly rate of $179 per room for this conference's attendees and sponsors. Please book your room at the link here by August 31st, 2024 to receive the discounted group rate.  

GLOBAL ONCOLOGY PROJECT

Click this link to learn more about our ongoing project building a 200-bed cancer hospital in Nepal: https://binayfoundation.org/cancer-hospital/

Course summary
Available credit: 
  • 5.25 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.25 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 5.25 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 5.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 5.25 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 5.25 Contact Hours.
Course opens: 
05/06/2024
Course expires: 
11/21/2024
Event starts: 
09/21/2024 - 8:00am PDT
Event ends: 
09/21/2024 - 4:00pm PDT
Cost:
$150.00
Add to calendar: 

September 21st, 2024

All times are listed in Pacific Time (PT)

07:00 AM – 08:00 AM  Breakfast, Registration, & Exhibits

08:00 AM – 08:05 AM  Welcome

08:05 AM – 08:20 AM  Opening Remarks

08:20 AM – 10:00 AM  Session 1: Loco-Regional Therapy in Breast Cancer

Session Chair: Sasha Stanton, MD, PhD

08:20 AM – 08.40 AM  Breast Cancer Surgery - Angelena Crown, MD

08:40 AM – 09:00 AM  Breast Cancer Radiation Oncology - L. Christine Fang, MD

09:00 AM – 10:00 AM  Case-Based Discussion - Michalina Kupsik, MD; Suzette Miranda, MD; Ying Zhuo, MD

10:00 AM – 10:25 AM  Break & Exhibits

10:25 AM – 11:40 AM  Session 2: Metastatic Breast Cancer

Session Chair: Fengting Yan, MD, FACP

10:25 AM – 10:45 AM  Updates in the Management of Metastatic Breast Cancer - Bernard Tawfik, MD

10:45 AM – 11:40 AM  Case-Based Discussion - Danbin Xu, MD, PhD; Zheng Topp, MD

11:40 AM – 12:40 PM  Lunch & Exhibits

12:40 PM – 01:55 PM  Session 3: Uterine Cancer

Session Chair: Fernanda Musa, MD

12:40 PM – 01:00 PM  New Therapeutic Strategies in Uterine Cancer - Fernanda Musa, MD

01:00 PM – 01:55 PM  Case-Based Discussion - Jenna Emerson, MD, FACOG; Julia Fehniger, MD

01:55 PM – 03:10 PM  Session 4: Cervical Cancer and Ovarian Cancer

Session Chair: Kalyan Banda, MD

01:55 PM – 02:15 PM  Ovarian and Cervical Cancer Update - Joshua Press, MD, MSc

02:15 PM – 03:10 PM  Case-Based Discussion - Tanja Pejovic, MD; Jenna Kahn, MD

03:10 PM – 03:15 PM  Closing Remarks

Hyatt Regency Portland at the Oregon Convention Center
375 NE Holladay Street
Portland, OR 97232
United States

A limited number of guestrooms are reserved at the Hyatt Regency Portland at the Oregon Convention Center for the participants of this meeting at a discounted rate of $179 per night. The room rate does not include any additional fees or applicable taxes.

GROUP CODE: G-MBR6

CUTOFF - Saturday, August 31st 2024

Please use the link below to reserve your room for the discounted rate. The rate is good through Saturday, August 31st. 

https://www.hyatt.com/en-US/group-booking/PDXRP/G-MBR6

 

IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:

All conflict of interest has been identified and mitigated for individuals in control of contents.

PLANNING COMMITTEE DISCLOSURE STATEMENT:

None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.

 

Course Director(s)

Binay Shah, MD, MHA

has no relevant financial relationships to disclose at this time.
Conference Chair(s)

Fengting Yan, MD

has no relevant financial relationships to disclose at this time.
Session Chair(s)

Kalyan Banda

has a financial relationship (Other) with Eli Lily ;.
has a financial relationship (Other) with Kineta;.
has a financial relationship (Other) with Pfizer ;.
has a financial relationship (Other) with Regeneron;.
has a financial relationship (Other) with MorphoSys;.

Fernanda Musa, MD MS

has a financial relationship (Professional Services) with GSK ;.
has a financial relationship (Professional Services) with Duality Bio/ BioNTech;.
has a financial relationship (Professional Services) with OncLive;.
has a financial relationship (Professional Services) with GSK;.
has a financial relationship (Professional Services) with Topline Bio;.
has a financial relationship (Professional Services) with Merck;.
has a financial relationship (Professional Services) with Daiichi Sankyo;.
has a financial relationship (Professional Services) with Astra Zeneca;.
has a financial relationship (Professional Services) with AADI;.

Sasha Stanton, MD PhD

has a financial relationship (Professional Services) with Margenza;.
has a financial relationship (Grant Or Contract) with IMV Inc;.
has a financial relationship (Professional Services) with Stanford Prebys Burnham;.

Fengting Yan, MD

has no relevant financial relationships to disclose at this time.
Speaker/Topic Presenter(s)

Angelena Crown, MD

has no relevant financial relationships to disclose at this time.

JENNA EMERSON

has no relevant financial relationships to disclose at this time.

L. Christine Fang, M.D.

has no relevant financial relationships to disclose at this time.

Julia Fehniger, MD

has a financial relationship (Other) with GSK;.

Joshua Press, MD, MSc

has a financial relationship (Other) with AstraZeneca;.
has a financial relationship (Other) with GlaxoSmithKline (GSK);.

Bernard Tawfik, MD

has no relevant financial relationships to disclose at this time.
Case Presenter(s)

Jenna Kahn

has no relevant financial relationships to disclose at this time.

Michalina Kupsik

has no relevant financial relationships to disclose at this time.

Suzette Miranda

has a financial relationship (Professional Services) with Mentor Worldwide, LLC;.

Tanja Pejovic, MD, PhD

has no relevant financial relationships to disclose at this time.

Zheng Topp, M.D.

has a financial relationship (Professional Services) with Astrazeneca;.

Danbin Xu, MD, PhD

has a financial relationship (Other) with GenomiCare;.

Ying Zhuo, MD

has no relevant financial relationships to disclose at this time.

Available Credit

  • 5.25 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.25 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 5.25 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 5.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 5.25 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 5.25 Contact Hours.
Vendor  List  
NameSponsorship typeRequester  Name
Eisai12' X 12' FeaturedJulie Mullin
MerckTabletop ExhibitSarah Olson
PfizerTabletop ExhibitJessica Fichtel
Eli LillyTabletop ExhibitKevin Pedigo
Daiichi Sankyo, Inc.Tabletop ExhibitSam Sakamaki
GileadTabletop ExhibitAngela Witkin

 

 

Price

Cost:
$150.00
Please login or register to take this course.

POLICY ON INDUSTRY EMPLOYEE'S PARTICIPATION IN MARKETING/EDUCATION ACTIVITY AT THE CONFERENCE: 

All marketing and product promotion activities must occur in the designated exhibit hall or product theater space separate from the area where this accredited continuing education takes place. 

The exhibit and product promotion space is reserved only for companies that have purchased marketing and product promotion slots at the conference.  The individual registration fee doesn't include marketing or product theater privileges. Please refer to the sponsorship handbook for the types of marketing activities included in your display/sponsorship fees. 

If your company has NOT purchased a marketing opportunity such as an exhibit table, product theater slot or another type of marketing opportunity, you may not participate in any marketing activity or attempt to educate healthcare providers about your product or service. Industry attendees of companies without marketing opportunities must refrain from interacting with healthcare providers at this meeting in any form, including introducing themselves as an employee of the company, discussing the care of patients, handing out flyers and brochures, inviting participants to the company's other programs, etc.

Violating this policy will result in a fine equivalent to a general display fee for that conference. 

 

NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:

If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:

  • If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
  • If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event. 
  • If your company has NOT purchased a display table at the event AND you attended the meeting paying a full industry registration fee, BUT YOU PARTICIPATED IN MARKETING AND PROMOTIONAL ACTIVITIES, you will be billed a full GENERAL DISPLAY FEE for that event. 

Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.

CANCELLATION POLICY

You may cancel your enrollment at any time. Cancellation fees apply as below:

  • 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
  • No refunds will be issued if registration is canceled after that date.  

No credits will be offered if you do not complete all required steps of this activity, including registration and participation in the live meeting.